STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] ELI LILLY & Co SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Lilly Endowment Inc. filed a Form 144 notice covering a proposed sale of 305,000 shares of Eli Lilly and Company common stock through Fidelity Capital Markets, with an aggregate market value of $323,208,500. The notice lists 945,383,757 Eli Lilly shares outstanding. The Endowment’s shares being sold trace back to a large historical gift; it reports acquiring 38,400,000 Eli Lilly common shares via a gift from the J.K. Lilly Sr. Trust dated in the 1930s–1940s.

The filing also details extensive recent selling activity by Lilly Endowment. Over the past three months, it executed multiple Eli Lilly stock sales on the NYSE and NASDAQ, including transactions such as 351,015 shares on 10/01/2025 for gross proceeds of $284,653,451.48 and 305,000 shares on 11/12/2025 for $308,411,211.50. Individual daily trades during this period often exceeded 100,000 shares, with gross proceeds frequently above $80 million per day.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing related to LLY disclose?

The Form 144 shows Lilly Endowment Inc. intends to sell 305,000 shares of Eli Lilly and Company common stock through Fidelity Capital Markets, with an aggregate market value of $323,208,500 on the NYSE and NASDAQ.

How many Eli Lilly (LLY) shares are outstanding in this notice?

The notice states that the number of Eli Lilly and Company common shares outstanding is 945,383,757.

What is the origin of Lilly Endowment’s Eli Lilly (LLY) shares being sold?

Lilly Endowment reports acquiring 38,400,000 Eli Lilly common shares as a gift on 02/10/1948 from the J.K. Lilly Sr. Trust, with the donor’s acquisition date listed as 01/21/1937.

What recent Eli Lilly (LLY) stock sales has Lilly Endowment reported in the past 3 months?

The notice lists numerous Eli Lilly stock sales, including 351,015 shares on 10/01/2025 for $284,653,451.48 and 305,000 shares on 11/12/2025 for $308,411,211.50, along with many other large daily transactions.

Who is the broker for the proposed Eli Lilly (LLY) share sale?

The proposed sale of 305,000 Eli Lilly common shares will be handled by Fidelity Capital Markets, located at 640 Fifth Avenue, New York, NY 10019.

What representation does the seller make in the Form 144 for Eli Lilly (LLY)?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Lilly Eli & Co

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

948.45B
943.30M
0.16%
83.87%
0.9%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS